The US Drug Watchdog Wants To Hear From Yaz-Yasmin Users About Possible Blood Clots, Heart Attacks and Strokes

Share Article

The US Drug Watchdog is doing everything possible to alert women who are using the birth control pills called Yaz, or Yasmin about potentially severe side effects.The group is saying, "we are talking about blood clots, heart attacks, strokes and other potentially extremely serious medical side effects from the use of these drugs. We are asking all young women to share this press release with their friends or girlfriends who may be using Yaz, or Yasmin." If an individual has suffered any medical side effects after taking the birth control drugs called Yaz, or Yasmin, they should call the US Drug Watchdog Immediately at 866-714-6466, or contact the group via its web site at Http://USDrugWatchdog.Com.

News Image

The US Drug Watchdog is intensifying its initiative to inform all US women about potentially severe side effects such as blood clots, heart attacks, strokes, or other extremely serious medical issues associated with the use of the very popular birth control pills called Yaz, or Yasmin. The group is saying, "millions of young women are using these the Yaz, or Yasmin birth control pills, and we do not think they understand the potentially serious medical side effects. We are also asking all women to put this press release on their Facebook, or MySpace web sites in order to get the word out about what could be very big problems with Yaz, or Yasmin." For more information, please contact the US Drug Watchdog anytime at 866-714-6466, or contact the group via its web site at Http://USDrugWatchdog.Com.

What has the US FDA said about Yaz, or Yasmin? According to the US Drug Watchdog, "yes, the FDA sent a warning letter to the maker of Yaz and Yasmin about its misleading advertising, the FDA notes that the side effects of Yaz/Yasmin are more dangerous than those of other oral contraceptives because the drug contains drospirenone, a progestin that can elevate potassium levels in the blood. Yaz/Yasmin and its recently approved generic version is the only approved oral contraceptive to contain drospirenone." The US Drug Watchdog is calling on all women who use birth control pills to please help us get the word out about Yaz, and Yasmin." If a Yaz, or Yasmin birth control user has any medical problems, or issues after using these drugs they should contact the US Drug Watchdog immediately at 866-714-6466, or contact the group via its web site at http://USDrugWatchdog.Com.

What if a Yaz, or Yasmin user has had a medical complication, or medical side effect from the use these birth control pills? The US Drug Watchdog is saying if you have a medical side effect or medical issue resulting from the possible use of Yaz or Yasmin we are encouraging women to contact them at 866-714-6466, or contact the group via its web site at Http://USDrugWatchdog.Com.

Is there a difference between Yaz and Yasmin? According to the US Drug Watchdog, "the only difference between the two pills is that the estradiol in Yaz is lower than in Yasmin. but it is not the estradiol that causes most problems, it is the type of progesterone called drosperinone. The amount of drosperinone is the same in both of the pills." For more information please contact the US Drug Watchdog anytime at 866-714-6466, or contact the group via its web site at Http://USDrugWatchdog.Com.

According to the US Drug Watchdog, "because of the popularity of the birth control pills called Yaz, or Yasmin, this is the most important pharmaceutical initiative we have ever been involved in for US women. If any Yaz, or Yazmin birth control pill user has suffered any severe medical side effects, to include blood clots, heart attacks, strokes, or other serious medical conditions, we want to hear from them immediately." Yaz, or Yasmin birth control pill users can contact the US Drug Watchdog anytime at 866-714-6466, or contact the group via its web site at Http://USDrugWatchdog.Com.

US Federal Court Case Number- 1:09cv00857

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

M Thomas Martin
Visit website